Keyword Connections

duchenne muscular dystrophy

Journals

6

1 Journal of magnetic resonance imaging : JMRI

2 Frontiers in bioengineering and biotechnology

3 Biochemical and biophysical research communications

4 Nature structural & molecular biology

5 the lancet diabetes & endocrinology

6 Taiwanese journal of obstetrics & gynecology

Research Groups

0

No Research Group Connected

Bibliographies

30

1 Amelioration of intracellular Ca regulation by exon-45 skipping in Duchenne muscular dystrophy-induced pluripotent stem cell-derived cardiomyocytes.

2 SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks.

3 Assessment of 6 STR loci for prenatal diagnosis of Duchenne Muscular Dystrophy.

4 Biomaterials and Advanced Biofabrication Techniques in hiPSCs Based Neuromyopathic Disease Modeling.

5 fat embolism after fractures in duchenne muscular dystrophy: an underdiagnosed complication? a systematic review

6 duchenne muscular dystrophy: overview and future challenges

7 living with severe physical impairment, duchenne's muscular dystrophy and home mechanical ventilation

8 serum creatinine distinguishes duchenne muscular dystrophy from becker muscular dystrophy in patients aged ≤3 years: a retrospective study

9 targeted exon skipping to correct exon duplications in the dystrophin gene

10 context dependent effects of chimeric peptide morpholino conjugates contribute to dystrophin exon-skipping efficiency

11 efficient restoration of the dystrophin gene reading frame and protein structure in dmd myoblasts using the cindel method

12 echocardiographic image quality deteriorates with age in children and young adults with duchenne muscular dystrophy

13 mechanism of deletion removing all dystrophin exons in a canine model for dmd implicates concerted evolution of x chromosome pseudogenes

14 concurrent label-free mass spectrometric analysis of dystrophin isoform dp427 and the myofibrosis marker collagen in crude extracts from mdx-4cv skeletal muscles

15 Association Between Myocardial Oxygenation and Fibrosis in Duchenne Muscular Dystrophy: Analysis by Rest Oxygenation-Sensitive Magnetic Resonance Imaging.

16 The palisade layer of the poxvirus core is composed of flexible A10 trimers.

17 Downregulation of the NLRP3 inflammasome by adiponectin rescues Duchenne muscular dystrophy

18 Small-molecule activation of lysosomal TRP channels ameliorates Duchenne muscular dystrophy in mouse models.

19 Dysregulation of Calcium Handling in Duchenne Muscular Dystrophy-Associated Dilated Cardiomyopathy: Mechanisms and Experimental Therapeutic Strategies.

20 Human Galectin-1 Improves Sarcolemma Stability and Muscle Vascularization in the mdx Mouse Model of Duchenne Muscular Dystrophy

21 Expression of dystrophin -glycoprotein complex at the skeletal muscle sarcolemma in Duchenne muscular dystrophy

22 Ultra-structural time-course study in the C. elegans model for Duchenne muscular dystrophy highlights a crucial role for sarcomere-anchoring structures and sarcolemma integrity in the earliest steps of the muscle degeneration process

23 Development of a high-throughput screen to identify small molecule enhancers of sarcospan for the treatment of Duchenne muscular dystrophy

24 current challenges and future directions in recombinant aav-mediated gene therapy of duchenne muscular dystrophy

25 therapeutic potential of matrix metalloproteinases in duchenne muscular dystrophy

26 chronic administration of a leupeptin-derived calpain inhibitor fails to ameliorate severe muscle pathology in a canine model of duchenne muscular dystrophy

27 anestesia em paciente portador de distrofia muscular de duchenne: relato de casos anestesia en un paciente portador de distrofia muscular de duchenne: relato de casos anesthesia for duchenne muscular dystrophy patients: case reports

28 The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy

29 Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

30 T1-Mapping and extracellular volume estimates in pediatric subjects with Duchenne muscular dystrophy and healthy controls at 3T